Advanced Search

 

Study ID Status Title Patient Level Data
113009 Completed A six week randomized, double-blind, multi-center, placebo-controlled, exploratory, adaptive design study to explore the antidepressant properties of the p38 MAP kinase inhibitor GW856553 compared to placebo in adult subjects with Major Depressive Disorder Study Listed on ClinicalStudyDataRequest.com
113014 Completed Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of MT 400 Tablets or Naproxen Sodium Tablets on Chromosomal Aberrations (CA) in Peripheral Blood Lymphocytes Study Listed on ClinicalStudyDataRequest.com
113017 Completed 2008 Update to Integrated Clinical Trial (ICT - also known as CV modeling) analysis for AVANDIA® (rosiglitazone maleate).
113018 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
113020 Completed A Proof of Concept Study for GSK2248761 (An Extension of NV-05A-002: A Phase I/IIa Double-Blind Study to Evaluate the Safety and Tolerability, Antiretroviral Activity, Pharmacokinetics and Pharmacodynamics of IDX12899 in Antiretroviral Treatment-Naive HIV-1 Infected Subjects, completed by Idenix)
113022 Completed Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of single intravenous dose(s) and a single oral dose of GW856553 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
113030 Completed Evaluation of the duration of oral combination therapy in Type 2 diabetes, prior to the initiation of insulin in the UK
113038 Completed Monitoring of specific birth defects associated with exposure to Lamotrigine in pregnancy through the EUROCAT network
113039 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_1 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_2 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_3 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_4 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_5 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_6 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113039_7 Completed Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
113043 Completed Modulation of beta-amyloid levels in CSF and plasma by GSK933776 in patients with mild Alzheimer’s disease or mild cognitive impairment Study Listed on ClinicalStudyDataRequest.com
113045 Completed A Phase I Study to Evaluate the Effect of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 Pharmacokinetics and to Assess the Effect of GSK2248761 on CYP450 Probe Drugs in Healthy Adult Subjects
113046 Active not recruiting A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.
113049 Completed A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathy Study Listed on ClinicalStudyDataRequest.com
113055 Completed Evaluation of GSK Biologicals’ Boostrix™ in healthy adults, 10 years after previous booster vaccination Study Listed on ClinicalStudyDataRequest.com
113060 Completed Evaluation of GSK Biologicals’ Boostrix™ Polio in healthy adults, 10 years after a booster vaccination Study Listed on ClinicalStudyDataRequest.com
113063 Completed Summing up the effectiveness and safety by using Seretide Diskus Powder inhalator 2 times daily 50/250mg for patients with moderate/serious Asthma
113068 Completed See Detailed Description Section as Official Study Title is too long to fit in this field
113073 Completed A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of GSK573719 Administered Once- and Twice-Daily in Subjects with COPD Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.